Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Medtronic
Accenture
Daiichi Sankyo
Moodys
Cantor Fitzgerald
Queensland Health
Colorcon
UBS

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020429

« Back to Dashboard

NDA 020429 describes ORUDIS KT, which is a drug marketed by Wyeth Cons and is included in one NDA. Additional details are available on the ORUDIS KT profile page.

The generic ingredient in ORUDIS KT is ketoprofen. There are twenty-seven drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
Summary for 020429
Tradename:ORUDIS KT
Applicant:Wyeth Cons
Ingredient:ketoprofen
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 020429

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Oct 6, 1995TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
US Army
QuintilesIMS
Fish and Richardson
Merck
Colorcon
Johnson and Johnson
Moodys
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.